Log in

6132 HJ Science Co., Ltd. HKEX · China

HJ Science Co. (6132) news

HJ Science Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6132, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest HJ Science Co. news

We have not published a story on HJ Science Co. yet. When there is news, it will appear here.

Questions about HJ Science Co.

What is the ticker symbol of HJ Science Co.?

HJ Science Co., Ltd. trades under the ticker 6132 on HKEX.

Where is HJ Science Co. listed?

HJ Science Co., Ltd. is listed on HKEX.

Which country or territory is HJ Science Co. listed under?

Our directory records HJ Science Co., Ltd. under China.

What does HJ Science Co. do?

Our directory classifies HJ Science Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of HJ Science Co.?

The ISIN recorded for HJ Science Co., Ltd. is CNE100007PD2.

Does aibio.space cover HJ Science Co.?

aibio.space lists HJ Science Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to HJ Science Co.?

Companies in our directory listed in the same country and business area as HJ Science Co.: Hualan Biological Engineering, Fujian Haixi Pharmaceuticals Co., Beijing Bohui Innovation Biotechnology Group Co., Liaoning Chengda Biotechnology Co., Beijing Kawin Technology Share-Holding Co., Qingdao Vland Biotech INC..

Investor discussion: HJ Science Co.

Members talk about HJ Science Co. (6132). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at HJ Science Co., newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: GLOBAL OFFERING. Source

Press releases

Headlines of HJ Science Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    Articles of Association

  2. HKEXnews

    POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 14 SEPTEMBER 2026

  3. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  4. HKEXnews

    H SHARE INCENTIVE SCHEME

  5. HKEXnews

    NOTICE OF EXTRAORDINARY GENERAL MEETING

  6. HKEXnews

    (1) PROPOSED ADOPTION OF THE 2026 H SHARE INCENTIVE SCHEME (2) GENERAL MANDATE TO BUY BACK H SHARES (3) PROPOSED CHANGE OF COMPANY NAME (4) PROPOSED AMENDMENTS TO THE ARTICLES (5) PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTORS AND (6) NOTICE OF EGM

  7. HKEXnews

    (1) PROPOSED ADOPTION OF THE 2026 H SHARE INCENTIVE SCHEME (2) PROPOSED CHANGE OF COMPANY NAME (3) PROPOSED AMENDMENTS TO THE ARTICLES (4) CHANGE OF NON-EXECUTIVE DIRECTORS

  8. HKEXnews

    Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications

  9. HKEXnews

    Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications

  10. HKEXnews

    STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF THE OVER-ALLOTMENT OPTION

  11. HKEXnews

    ANNOUNCEMENT OF ALLOTMENT RESULTS

  12. HKEXnews

    Nomination Committee - Terms of Reference

  13. HKEXnews

    Remuneration and Appraisal Committee - Terms of Reference

  14. HKEXnews

    Audit Committee - Terms of Reference

  15. HKEXnews

    Documents on Display

  16. HKEXnews

    GLOBAL OFFERING

  17. HKEXnews

    PHIP (1st submission)

  18. HKEXnews

    OC Announcement - Appointment

  19. HKEXnews

    Application Proof (1st submission)

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:6132 on TradingView.

Listing details

HJ Science Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6132, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
HJ Science Co., Ltd.
Ticker
6132
Listing
HKEX
Country or territory
China
Business scope
Biotechnology
ISIN
CNE100007PD2
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.